Prevalence and CO-Prevalence of Comorbidities Among Patients with Type 2 Diabetes Mellitus Living in Puerto Rico, USA

Author(s)

Garcia-Rivera E1, Ruiz K2, Miranda E3, Mejia L3, Pinzon A4, Marques-Goyco C3, Quijada J3, Monsanto H3, Orengo J3
1University of Puerto Rico, Carolina , PR, USA, 2University of Puerto Rico, San Juan, PR, USA, 3Merck & Co., Inc., Kenilworth, NJ, USA, 4MSD (IA) Corp - CL Branch, Santiago, Chile

OBJECTIVES: To estimate the prevalence of common comorbidities and describe the healthcare utilization patterns in patients with type 2 diabetes mellitus (T2DM) in Puerto Rico.

METHODS: This is a descriptive study using healthcare claims data from patients with T2DM (based on ICD-9 diagnosis code) from most public and private healthcare insurance companies providing services in Puerto Rico in 2013 (representing more than 90% of insured population). Descriptive analyses by age, sex, type of insurance, health region, and type of medical encounter were done using frequency and percent for categorical data or means or median (with corresponding standard deviation or interquartile range) for continuous variables.

RESULTS: A total of 3,100,636 claims were identified from 485,866 adult patients with T2DM. Most patients were women (276,400; 57%), older than 65 years (235,390; 48%), from the Puerto Rico health regions of Caguas (79,604; 16%), Metro (66,280; 14%), or Bayamon (62,673; 13%) with private health insurance (371,806; 77%). The number of claims per patient ranged from 1 to 339. A mean of 6.3 claims (SD±9.99) and a median of 3 claims (Q1 1- Q3 8) per subject were identified. Of the 3,100,636 claims most (74%) were related to the diagnosis of diabetes (1,829,2015; 59%) or to cardiovascular diseases (458,219; 15%) and associated to outpatient services (2,722,727; 88%). The most prevalent comorbidities associated with healthcare utilization in these patients were hypertension (235,277; 48%), hyperlipidemia (197,449; 41%), neuropathy (100,471; 21%); renal disease (71,517; 15%), and retinopathy (61,837; 13%).

CONCLUSIONS: A high prevalence of comorbidities and use of healthcare services were identified in patients with T2DM, especially in older adults. Since most comorbidities were due to diabetes-related conditions, this analysis highlights the importance of early diagnosis and adequate management of T2DM patients to avoid preventable burden to the patient and to the healthcare system.

Conference/Value in Health Info

2021-05, ISPOR 2021, Montreal, Canada

Value in Health, Volume 24, Issue 5, S1 (May 2021)

Code

PDB18

Topic

Epidemiology & Public Health

Topic Subcategory

Disease Classification & Coding, Public Health

Disease

Cardiovascular Disorders, Diabetes/Endocrine/Metabolic Disorders, Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×